(53) updated a meta-analysis of NAFLD versus circulating irisin levels and found no difference exciting in the level of circulating irisin between NAFLD and non-NAFLD patients. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.